SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer
Clinical trial NCT06465563 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06465563
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2026-12-30
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.